Prenetics Global Limited (PRE) News
Track canonical SquawkNews coverage tagged to PRE, Prenetics Global Limited. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 9 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Predict H1 Sales Revenue €4.01 Mln
Predict SpA MIL:PRE
NEWS | Sep 25, 2026, 04:44 PM UTC
L
Pensana Announces Construction Schedule For Longonjo Mine Extended To Late 2028
Pensana PLC LSE:PRE
NEWS | Sep 25, 2026, 06:20 AM UTC
H
Prenetics Global Q2 2026 Earnings Call: Complete Transcript
Prenetics Global (NASDAQ: PRE ) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For re
LIVE | Sep 21, 2026, 08:40 AM UTC
L
Prenetics Global price target set at $37.00 by B. Riley
B. Riley Securities announced a $37.00/share price target for Prenetics Global.
EQUITY | Aug 27, 2026, 05:54 PM UTC
L
PRE - Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
PRE - Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
EARNINGS | Aug 26, 2026, 12:47 PM UTC
L
Prenetics' IM8 names Lily Collins global ambassador, shareholder
Prenetics' IM8 announces actress and producer Lily Collins as its global ambassador and shareholder in a multi-year partnership.
MNA | Aug 20, 2026, 01:01 PM UTC
L
Prenetics Global initiates FY2027 guidance for $400M+ IM8 revenue
Prenetics Global (NASDAQ: PRE) initiates FY2027 guidance, targeting $400 million+ in IM8 revenue.
EARNINGS | Aug 18, 2026, 11:35 AM UTC
L
Prenetics’ IM8 reports Q2 2026 revenue +288% YoY; guides FY 2026 higher
Prenetics (PRE) says its IM8 reported Q2 2026 revenue growth of 288% YoY and raises FY 2026 IM8 revenue guidance to $220—230 million.
EARNINGS | Aug 18, 2026, 11:30 AM UTC
L
PRE appoints Caroline Levy, veteran consumer analyst, as independent director
Prenetics, the parent of IM8, appoints II-ranked Caroline Levy, a veteran Wall Street consumer analyst, as an independent director.
REGULATION | Aug 17, 2026, 12:32 PM UTC
L
PRE PT raised from $30 to $40, maintains Buy @ Benchmark
PRE PT raised from $30 to $40, maintains Buy @ Benchmark
EQUITY | Jul 15, 2026, 01:23 PM UTC
H
Sector Update: Healthcare Stocks Fall Late Afternoon
() -- Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.9%. The iShares Biotechnology ETF (IBB) shed 0.4%
EARNINGS | Jul 14, 2026, 07:46 PM UTC
H
Prenetics Global Announces Closing Of $1B In Growth Financing From General Catalyst’s Customer Value Fund; Co. Raises FY26 IM8 Revenue Guida
IM8 is the fastest-growing premium supplement brand ever recorded — over 50 million servings delivered to date, with approximately 200,000 servings currently delivered daily, and an order every 27 seconds Prenetics raise
EARNINGS | Jul 14, 2026, 06:01 PM UTC
H
PRE Prenetics’ im8 secures $1B growth financing from general catalyst’s customer value fund (cvf) Prenetics global Ltd: raises full-year 202
PRE Prenetics’ im8 secures $1B growth financing from general catalyst’s customer value fund (cvf) Prenetics global Ltd: raises full-year 2026 im8 revenue guidance to $210–220M, up from $190–210M - Im8 expected to deliver
EARNINGS | Jul 14, 2026, 05:28 PM UTC